Abstracts should be submitted via the online submission system, which will open in autumn 2021.


The Scientific and Organising Committee encourages all researchers and practitioners to contribute to the congress programme by submitting an abstract.

Abstracts will be considered by the SOC for oral or poster presentation.

Late-breaking abstract submission system is now closed.

The deadline for submission was 6 April.

The ISOC would like to emphasise that late-breaking abstracts must match the following criteria:

  • Abstracts must be of exceptional interest and of scientific merit
  • Results were only available after the original abstract submission deadline
  • Results have not been included in any other sessions of the congress. Please review the congress programme to ensure that you are not repeating content already in the programme: https://www.epilepsycongress.org/ece/programme/
  • Results have not been presented elsewhere

Late-breaking abstracts will be reviewed by members of the ISOC and, in addition to the standard criteria applying to the abstract review, acceptance will depend on fulfilment of the special criteria listed above for late-breaking abstracts.

Please contact the Congress Secretariat at abstracts@epilepsycongress.org with any queries.

  1. Abstracts will not be accepted unless they are submitted online via the online abstract submission system before midnight (GMT) on 06 April 2020. Abstracts received after this date will NOT be accepted. Abstracts submitted by post, fax or email will NOT be considered.
  2. All abstracts should be written, submitted and presented in English with a maximum word count of 300 words (not including the abstract title, authors and institutions).
  3. Authors will be notified in writing in May 2020 as to whether or not their abstract has been accepted by the Abstract Review Committee. The decision of the committee is final and no correspondence will be entered into.
  4. Once an abstract has been accepted, the presenting author must register for the congress for final acceptance. An abstract presenter may not register as a day delegate. Proof of registration for the congress must be submitted to abstracts@epilepsycongress.org to finalise acceptance of the abstract.
  5. Abstracts accepted and presented at the congress will be published, subject to editorial review, on the congress website and details will appear in the printed Final Programme. Abstracts may be published in a supplement to ‘Epilepsia’.
  6. Authors who do not register for the congress will be excluded from publication.
  7. Instructions for both platform and poster presentations will be available on the congress website. Authors selected for oral presentations should use Microsoft PowerPoint only (PC Format).
  8. All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author.
  9. Each author is permitted to present once (not including invited lectures)
  1. Abstract submitters should ensure that the version submitted is the final one; changes will not be permitted once the deadline has passed.
  2. Institution information should be provided for all authors. Please include institution, city, state/ province and country but exclude department, division, laboratory, etc.
  3. A topic category for each abstract must be selected during the submission process; the abstract topics can be found in the section below.
  4. Abstracts should be structured in 4 sections as follows:
    Purpose: Should indicate the objectives of the work being presented
    Method: Should describe study material or subjects (e.g. number and type of patients), intervention and evaluation procedures.
    Results: Should summarise the main findings. Wherever possible, give numerical values, including means with SD or SEM, and statistical significance or confidence intervals.
    Conclusion: Should state briefly the conclusions reached in the work
  5. Up to 5 key words relating to the content of the abstract may be provided.
  6. Figures, tables and other illustrations may not be included.
  7. If the work was supported by funds provided by a commercial organisation this should be stated in a short acknowledgment at the end of the abstract. Other sources of funding may be acknowledged in the same way.
  8. Submission of multiple abstracts describing different components of the same study is not appropriate. All findings generated from the same study should be included in a single abstract.
  9. Abstracts containing single case reports will not usually be accepted, unless the report is of outstanding scientific or clinical interest because of the uniqueness of the findings or the sophistication of the investigations.
  10. Abstracts containing data considered to be insufficiently informative will not be accepted.
  11. Authors should use a concise title that indicates the content of the abstract. Abbreviations should be avoided in the title.
  12. For intervention studies (for example, therapeutic trials), type of design (prospective or retrospective, controlled or uncontrolled, randomised or observational, open vs. single-blind vs. double-blind), dosages, assessment methods and duration of follow-up should be specified.
  13. Non-proprietary names of drugs must be used throughout. If results are considered to be specific for a given proprietary product (for example, bio-equivalence studies), the non-proprietary name must still be used, followed by the proprietary name and the name of the manufacturers in brackets.
  14. Abbreviations should be used sparingly. For words that are abbreviated, use the whole term the first time, followed by the standard abbreviation in parenthesis.
  15. References should be used sparingly. They should be included within the text in brackets. For journals, mention first author “et al”, followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (e.g. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author “et al”, editor, title, publisher, city of publication, year and inclusive pages (e.g. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.).
  16. Submission of an abstract automatically implies acknowledgment that the work described was conducted in accordance with current ethical standards and regulations in biomedical research. Failure to adhere to these standards will result in rejection of the abstract.

A topic category for each abstract must be selected during the submission process; the abstract topics are as follows:

  1. Basic science (preclinical models, mechanisms, biomarkers and treatments)
  2. Classification, epidemiology, comorbidity, prognosis and outcome
  3. Clinical neurophysiology (EEG, MEG, evoked potentials, ENG/EMG)
  4. Clinical semiology (including non-epileptic paroxysmal events)
  5. Status epilepticus
  6. Clinical pharmacology (drug trials, pharmacokinetics/dynamics and alternative therapies)
  7. Epilepsy in special populations (gender aspects, pregnancy, intellectual disability, elderly)
  8. Neonatal seizures/syndromes, epileptic encephalopathies and childhood epilepsy syndromes
  9. Genetics (including genetic causes, pharmacogenetics and basic genetics)
  10. Neuroimaging (MRI, fMRI, EEG-fMRI, PET, SPECT)
  11. Neurostimulation and devices
  12. Epilepsy surgery and neuropathology
  13. Neuropsychology and psychiatry of epilepsy
  14. Organization of care and social issues
  15. Other

Abstract Submission:

Can I make changes to my abstract after submission?

You can make any changes you wish to the abstract even if the abstract has been submitted, but the changes must be made before the abstract submission deadline. Once the abstract submission deadline has passed, changes are not permitted unless they relate to the results of the study; in this case only, please contact abstracts@epilepsycongress.org.

Can I submit an abstract after the deadline?

Late abstracts will not be accepted.

May an Encore Abstract be submitted?

Yes an Encore Abstract may be submitted providing that there is no copyright issue with the original publisher.

Abstract Acceptance:

When will I know if my abstract has been accepted?

Authors will be notified of the acceptance/ rejection of their abstract in May 2020.

How will I receive the information from the Congress Secretariat?

Contact details provided at the time of submission will be used for all correspondence related to the congress. Please ensure that the correct details are entered.

How will my abstract be presented at the congress?

Most abstracts are accepted for poster presentations, a few are selected for oral presentation. You will be informed of the format of your presentation at the time of acceptance notification.

My colleague has received confirmation of his acceptance and I did not, is there something wrong?

There may be a problem with your email address, therefore please contact abstracts@epilepsycongress.org

Abstracts – Onsite Information:

Are e-posters be available at the congress?

E-posters are not available at the congress.

Do posters have to stay up for the duration of the congress?

All information relating to posters is available in the section below.

Where will the poster area be situated?

Posters will be exhibited in the poster area on level -1 of the congress centre.

Can I include videos beside my poster?

AV equipment is not provided by the congress. Should you wish to order any specific equipment to complement your poster, please contact the Congress Secretariat in order to receive a quotation.

How can I make my poster more attractive?

Please note that colourful posters are more effective and attractive. When choosing a background, remember that neutral or grey colours will be easier on the eyes than a bright colour. Colour photos also look best when mounted on a grey background. Poster dimensions are specified here.

Abstracts – General Queries:

Which reference number should I use when I send a query to the Congress Secretariat?

The personal ID Reference Number should be mentioned in all correspondence.

I am not the first author; can I present the poster on behalf of my colleagues?

Presentation by a second author may be allowed. Once your registration has been completed, please contact abstracts@epilepsycongress.org. Please note however that each author is permitted to present only once during the congress (not including invited lectures).

Can the presenting author pay one-day registration fee (for the day when the poster is displayed)?

No. Once an abstract has been approved, the presenting author must register for the entire congress for final acceptance. An abstract presenter may not register as a day delegate. Non-registered authors may be excluded from publication. Proof of registration for the congress must be submitted to abstracts@epilepsycongress.org to finalise acceptance of the abstract.

I am an invited speaker in the congress programme; do I need to submit an abstract?

Invited speakers are not required to submit abstracts to illustrate their talks.

I have been selected for a platform session but I would have preferred a poster presentation, what can I do?

During the abstract submission process you were asked if you would prefer poster or oral (platform) presentation, or if you do not have a preference.

The Abstract Review Committee (ARC) took this preference into account and did not select an abstract for platform presentation if the submitter indicated that s/he does not want a platform presentation.

However, if you indicated that you had no preference between poster and platform presentation, then the ARC has selected your work to be presented in a platform session because they felt that it was of high quality and that a large audience would be interested in knowing more about the study. It would be a shame not to use this opportunity to present your work! However if you are unable to make an oral presentation please contact the secretariat at abstracts@epilepsycongress.org for alternative arrangements.

How do I find information about the posters?

All information relating to posters is available in the section below.

Poster Display Dates

Posters will be rotated on a daily basis. Posters will be on display on either Monday, Tuesday or Wednesday. Presenters will be notified of the day their posters will be on display. Presenters must be at their posters between 13.00 and 15.00 on the day of display.

Set Up and Removal Times

Posters must be set up between 09.00 and 09.30 on the day of display. Materials to affix posters to the boards will be provided.

Posters may be taken down between 16.30 and 17.00 and must be removed on the day of display. The congress will not be held responsible for any posters that are left behind.

Location of the Poster Area

The poster area is located on level -1 of the congress centre.

Poster Board Size

The maximum available dimensions of the portrait poster boards are as follows:
90cm wide x 150cm high (portrait orientation).

It is not necessary to use the whole of the poster board for a poster, but a minimum poster size of A1 portrait (59cm wide x 84cm high) is recommended.

Remember! If the whole of the poster board is used, delegates may find it difficult to read what is at the bottom of the poster.

Any poster that overlaps an adjoining board will be removed.

Poster Number (P Number)

All poster presenters will receive a poster number e.g. p444. This will be used onsite for the poster board number. This poster number will also be referenced in the programme book, where the title of the abstracts and the authors’ details will be mentioned, as well as on the congress website, where all abstracts will be published.

Poster Presentation Guidelines

For any queries, please contact abstracts@epilepsycongress.org.

In order to encourage young researchers to participate in the 14th European Congress on Epileptology, bursaries will be awarded to a number of applicants who have submitted an abstract to the congress that stands out for its scientific quality.

Bursary awards assist awardees with costs in order to attend the congress, which may include registration, travel and accommodation.

Applications for bursaries will only be accepted from those who also submit an abstract.

The application for bursaries is now closed.

Requirements and Conditions

  • Applications for bursaries will only be accepted via the online abstract submission system for the 14th ECE.
  • At the time of application, the applicant must be 45 years of age or under. A copy of the applicant’s passport must be included with the application to verify date of birth.
  • The applicant must submit an abstract and receive a score higher than 3.5 out of 5.
  • The applicant may not have received a bursary to participate in an ILAE/IBE congress over the past four years.
  • The applicant must submit a short statement explaining why attendance at the ECE would be particularly relevant to his/her present appointment or activity in the field of epilepsy, making sure to indicate the reason he/she requires funding to attend the congress and why he/she feels the application should be considered.
  • The applicant must declare if he/she has sourced any other funding to attend the ECE and disclose the nature of the funding.
  • The applicant must submit a signed reference from a person supporting his/her application (e.g. local ILAE Chapter representative, Head of Department of hospital or institution, etc.

Please contact the Congress Secretariat at bursary@epilepsycongress.org with any queries.

The ILAE plans to continue the successful Mentor-Mentee programme for trainees at the 14th ECE 2020.

This programme will involve the allocation of a mentor, an experienced individual in the research/clinical area in which trainee demonstrates an interest, to a trainee.

*Applications for the mentor-mentee programme are only available through the 14th ECE abstract system.

*Please note that the applicant must submit an abstract to the 14th ECE in order to be eligible to apply for the programme.

Extended Deadline:  17 January 2020


Criteria & Selection

  1. Trainees <35 years old
  2. At time of application:
  • for MDs: within 2 years of start of fellowship
  • for non-MDs: being enrolled in a graduate student programme (Masters or PhD)
  1. Submission/acceptance of an abstract for the 14th ECE
  2. Letter from supervisor indicating the applicant fulfills the criteria, including that the work in the abstract submitted is mostly the work of the applicant

Consideration for selection will be based on the above criteria.

If selected, the trainee will be allocated a mentor, invited to an evening event on Saturday, 4 July 2020, and also a meeting later in the congress.

Trainees will have the opportunity to meet with their mentors, as well as to listen to further individuals established in their careers in different regions of the world. The mentors will arrange to attend the trainees’ presentation/poster and also to further consultation.


How to Apply

Applications must be made through the 14th ECE abstract system.

If you have any queries please contact ece@epilepsycongress.org.

Platform Presentation Guidelines

To view platform presentation guidelines, please click here.